Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Nov 2002

Franchini M, Tagliaferri A, Rossetti G, Capra F, Veneri D, de Maria E, Pattacini C, Aprili G, Gandini G

Abstract excerpt

Between January 1999 and December 2001, 33 HIV-negative haemophiliacs with interferon-nonresponsive chronic hepatitis C were treated with interferon (IFN) alpha2b (5 MU three times weekly) and ribavirin (1-1.2 g daily) for 12 months. Four patients (12.1%) dropped out of the study due to adverse e...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemophilia A

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Ribavirin

Share to Treatment Failure

Source

Identifiers

PMID: 12410649
DOI: 10.1046/j.1365-2516.2002.00682.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12410649-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment.PMID 12410649Read ↗

Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes.Semantic proximity Read ↗

Treatment of chronic hepatitis C virus infection among Brazilian haemophiliacs.Semantic proximity Read ↗

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.Semantic proximity Read ↗

Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis.Semantic proximity Read ↗

Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.Semantic proximity Read ↗

Hepatitis C in haemophiliacs.Semantic proximity Read ↗

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia.Semantic proximity Read ↗

Peginterferon alpha-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases.Semantic proximity Read ↗

High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.Semantic proximity Read ↗

Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response.Semantic proximity Read ↗

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.Semantic proximity Read ↗

Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.